Back

Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular risk assessment & COVID Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Dimitrios Terentes-Printzios

National & Kapodistrian University of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Prognostic implications of cardiac 82-rubidium positron emission tomography in angina patients with no perfusion defects
Ms M. Rauf (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality
Professor R. Nowak (Detroit, US)
Abstract Slides
Presentation thumbnail
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study.
Ms A. Camps-Vilaro (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide
Doctor M. Sano (Kobe, JP)
Abstract Slides
Presentation thumbnail
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?
Mr T. Gudmundsson (Gothenburg, SE)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk assessment & COVID

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources